SCHEMBL6630

SCHEMBL6630

CCOC(=O)Cc1ccc(-c2ccc(-c3onc(C)c3N(C)CCCc3cccc(C(F)(F)F)c3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.40
HDAC6 Q9UBN7 4/20 0.40
HDAC8 Q9BY41 3/20 0.40
DHFR P00374 2/20 0.40
SYK P43405 1/20 0.39
THRB P10828 1/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
LTB4R2 Q9NPC1 1/20 0.37
PPARG P37231 2/20 0.37
PPARD Q03181 2/20 0.37
PPARA Q07869 2/20 0.37
HDAC4 P56524 1/20 0.37
MEN1 O00255 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6543 0.93 HDAC1 (0.40) HDAC1HDAC6HDAC8SYKTHRB
SCHEMBL6811 0.90 HDAC1 (0.42) HDAC1HDAC6HDAC8MAPTPPARG
SCHEMBL8174 0.89 MAOB (0.41) SYKLTB4R2
SCHEMBL7216 0.87 MAOB (0.41) MAPTKMT2AMEN1ALDH1A1
SCHEMBL11897090 0.87 HDAC1 (0.36) HDAC1HDAC6HDAC8THRBMAPT
SCHEMBL1859 0.86 KCNA3 (0.37) HDAC1HDAC6HDAC8THRBMAPT
SCHEMBL7176 0.86 HDAC1 (0.37) HDAC1HDAC6HDAC8THRBMAPT
SCHEMBL6934 0.86 FFAR4 (0.46) HDAC1HDAC6HDAC8THRBPPARG
SCHEMBL2337994 0.82 HDAC6 (0.43) HDAC1HDAC6HDAC8DHFRSYK
SCHEMBL6878 0.82 PTGES (0.37) HDAC1HDAC6HDAC8MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed